Role of caspase-1 in regulation of triglyceride metabolism

Proceedings of the National Academy of Sciences of the United States of America

Volumn 110, Issue 12, 2013, Pages 4810-4815

  Kotas, Maya E ^a   Jurczak, Michael J ^a   Annicelli, Charles ^a   Gillum, Matthew P ^a   Cline, Gary W ^a   Shulman, Gerald I ^a,b   Medzhitov, Ruslan ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF IOWA   (United States)

Author keywords

Inflammasome; Inflammation; Lipoprotein

Indexed keywords

INFLAMMASOME; INTERLEUKIN 1; INTERLEUKIN 1BETA CONVERTING ENZYME; LIPOPROTEIN LIPASE; TRIACYLGLYCEROL;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BODY WEIGHT; CELL DEATH; CELL MEMBRANE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DYSLIPIDEMIA; ENZYME ACTIVITY; ENZYME INHIBITION; FAT TOLERANCE TEST; FEMALE; GLUCOSE HOMEOSTASIS; LIPID ABSORPTION; LIPID METABOLISM; LIPOGENESIS; MALE; METABOLIC REGULATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION;

ANIMALS; CASPASE 1; FATTY ACIDS; INTERLEUKIN-1; LIPID METABOLISM; MICE; MICE, KNOCKOUT; TRIGLYCERIDES;

EID: 84875261954     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.1301996110     Document Type: Article

References (43)

1. Hotamisligil GS, Erbay E (2008) Nutrient sensing and inflammation in metabolic diseases. Nat Rev Immunol 8(12):923-934.
2. Gregor MF, Hotamisligil GS (2011) Inflammatory mechanisms in obesity. Annu Rev Immunol 29:415-445.
3. Weissman C (1990) The metabolic response to stress: An overview and update. Anesthesiology 73(2):308-327.
4. Gabay C, Kushner I (1999) Acute-phase proteins and other systemic responses to inflammation. N Engl J Med 340(6):448-454.
5. Hotamisligil GS, Arner P, Caro JF, Atkinson RL, Spiegelman BM (1995) Increased adipose tissue expression of tumor necrosis factor-alpha in human obesity and insulin resistance. J Clin Invest 95(5):2409-2415.
6. Weisberg SP, et al. (2003) Obesity is associated with macrophage accumulation in adipose tissue. J Clin Invest 112(12):1796-1808.
7. Xu H, et al. (2003) Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance. J Clin Invest 112(12):1821-1830.
8. Hotamisligil GS, Shargill NS, Spiegelman BM (1993) Adipose expression of tumor necrosis factor-alpha: Direct role in obesity-linked insulin resistance. Science 259(5091):87-91.
9. Uysal KT, Wiesbrock SM, Marino MW, Hotamisligil GS (1997) Protection from obesityinduced insulin resistance in mice lacking TNF-alpha function. Nature 389(6651): 610-614.
10. Lamkanfi M (2011) Emerging inflammasome effector mechanisms. Nat Rev Immunol 11(3):213-220.
11. Martinon F, Mayor A, Tschopp J (2009) The inflammasomes: Guardians of the body. Annu Rev Immunol 27:229-265.
12. Leemans JC, Cassel SL, Sutterwala FS (2011) Sensing damage by the NLRP3 inflammasome. Immunol Rev 243(1):152-162.
13. Wen H, et al. (2011) Fatty acid-induced NLRP3-ASC inflammasome activation interferes with insulin signaling. Nat Immunol 12(5):408-415.
14. Schroder K, Zhou R, Tschopp J (2010) The NLRP3 inflammasome: A sensor for metabolic danger? Science 327(5963):296-300.
15. Youm YH, et al. (2011) Elimination of the NLRP3-ASC inflammasome protects against chronic obesity-induced pancreatic damage. Endocrinology 152(11):4039-4045.
16. Keller M, Rüegg A, Werner S, Beer HD (2008) Active caspase-1 is a regulator of unconventional protein secretion. Cell 132(5):818-831.
17. Henao-Mejia J, et al. (2012) Inflammasome-mediated dysbiosis regulates progression of NAFLD and obesity. Nature 482(7384):179-185.
18. Vandanmagsar B, et al. (2011) The NLRP3 inflammasome instigates obesity-induced inflammation and insulin resistance. Nat Med 17(2):179-188.
19. Stienstra R, et al. (2010) The inflammasome-mediated caspase-1 activation controls adipocyte differentiation and insulin sensitivity. Cell Metab 12(6):593-605.
20. Netea MG, et al. (2006) Deficiency of interleukin-18 in mice leads to hyperphagia, obesity and insulin resistance. Nat Med 12(6):650-656.
21. Beutler BA, Cerami A (1985) Recombinant interleukin 1 suppresses lipoprotein lipase activity in 3T3-L1 cells. J Immunol 135(6):3969-3971.
22. Gurcel L, Abrami L, Girardin S, Tschopp J, van der Goot FG (2006) Caspase-1 activation of lipid metabolic pathways in response to bacterial pore-forming toxins promotes cell survival. Cell 126(6):1135-1145.
23. Shao W, Yeretssian G, Doiron K, Hussain SN, Saleh M (2007) The caspase-1 digestome identifies the glycolysis pathway as a target during infection and septic shock. J Biol Chem 282(50):36321-36329.
24. He F, Doucet JA, Stephens JM (2008) Caspase-mediated degradation of PPARgamma proteins in adipocytes. Obesity (Silver Spring) 16(8):1735-1741.
25. Guilherme A, Tesz GJ, Guntur KV, Czech MP (2009) Tumor necrosis factor-alpha induces caspase-mediated cleavage of peroxisome proliferator-activated receptor gamma in adipocytes. J Biol Chem 284(25):17082-17091.
26. Price SR, Mizel SB, Pekala PH (1986) Regulation of lipoprotein lipase synthesis and 3T3-L1 adipocyte metabolism by recombinant interleukin 1. Biochim Biophys Acta 889(3):374-381.
27. Grégoire F, et al. (1992) Interferon-gamma and interleukin-1 beta inhibit adipoconversion in cultured rodent preadipocytes. J Cell Physiol 151(2):300-309.
28. García MC, et al. (2006) Mature-onset obesity in interleukin-1 receptor I knockout mice. Diabetes 55(5):1205-1213.
29. Matsuki T, Horai R, Sudo K, Iwakura Y (2003) IL-1 plays an important role in lipid metabolism by regulating insulin levels under physiological conditions. J Exp Med 198(6):877-888.
30. Somm E, et al. (2005) Decreased fat mass in interleukin-1 receptor antagonistdeficient mice: impact on adipogenesis, food intake, and energy expenditure. Diabetes 54(12):3503-3509.
31. Chida D, et al. (2008) Increased fat:carbohydrate oxidation ratio in Il1ra (-/-) mice on a high-fat diet is associated with increased sympathetic tone. Diabetologia 51(9): 1698-1706.
32. Zorrilla EP, et al. (2007) Interleukin-18 controls energy homeostasis by suppressing appetite and feed efficiency. Proc Natl Acad Sci USA 104(26):11097-11102.
33. Ehnholm C (2009) Cellular Lipid Metabolism (Springer, Berlin).
34. Samuel VT, Shulman GI (2012) Mechanisms for insulin resistance: Common threads and missing links. Cell 148(5):852-871.
35. Bartelt A, et al. (2011) Brown adipose tissue activity controls triglyceride clearance. Nat Med 17(2):200-205.
36. de Roos B, et al. (2009) Attenuation of inflammation and cellular stress-related pathways maintains insulin sensitivity in obese type I interleukin-1 receptor knockout mice on a high-fat diet. Proteomics 9(12):3244-3256.
37. Van Diepen JA, et al. (2013) Caspase-1 deficiency in mice reduces triglyceride absorption and hepatic triglyceride secretion. J Lipid Res 54(2):448-456.
38. Millar JS, Cromley DA, McCoy MG, Rader DJ, Billheimer JT (2005) Determining hepatic triglyceride production in mice: Comparison of poloxamer 407 with Triton WR-1339. J Lipid Res 46(9):2023-2028.
39. Nakamura T, et al. (2010) Double-stranded RNA-dependent protein kinase links pathogen sensing with stress and metabolic homeostasis. Cell 140(3):338-348.
40. Lu B, et al. (2012) Novel role of PKR in inflammasome activation and HMGB1 release. Nature 488(7413):670-674.
41. Kuida K, et al. (1995) Altered cytokine export and apoptosis in mice deficient in interleukin-1 beta converting enzyme. Science 267(5206):2000-2003.
42. Sutterwala FS, et al. (2006) Critical role for NALP3/CIAS1/Cryopyrin in innate and adaptive immunity through its regulation of caspase-1. Immunity 24(3):317-327.
43. Folch J, Lees M, Sloane Stanley GH (1957) A simple method for the isolation and purification of total lipides from animal tissues. J Biol Chem 226(1):497-509.